Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SEROTONIN-UPTAKE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Overall, KL
      Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses

      VETERINARY JOURNAL
    2. Furusho, J; Matsuzaki, K; Ichihashi, I; Satoh, H; Yamaguchi, K; Kumagai, K
      Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome

      BRAIN & DEVELOPMENT
    3. Moller, SE; Larsen, F; Khan, AZ; Rolan, PE
      Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    4. Schmitt, JAJ; Kruizinga, MJ; Riedel, WJ
      Non-serotonergic pharmacological profiles and associated cognitive effectsof serotonin reuptake inhibitors

      JOURNAL OF PSYCHOPHARMACOLOGY
    5. Bissette, G
      Effects of sertraline on regional neuropeptide concentrations in olfactorybulbectomized rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    6. Hilborn, JW; Lu, ZH; Jurgens, AR; Fang, QK; Byers, P; Wald, SA; Senanayake, CH
      A practical asymmetric synthesis of (R)-fluoxetine and its major metabolite (R)-norfluoxetine

      TETRAHEDRON LETTERS
    7. Peterson, MC
      Reversible galactorrhea and prolactin elevation related to fluoxetine use

      MAYO CLINIC PROCEEDINGS
    8. Furusho, J; Kubagawa, T; Saitoh, N; Matsuzaki, K; Yamakawa, H; Iikura, Y
      The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor

      PEDIATRICS INTERNATIONAL
    9. Parker, NG; Brown, CS
      Citalopram in the treatment of depression

      ANNALS OF PHARMACOTHERAPY
    10. Kameda, K; Kusumi, I; Suzuki, K; Miura, J; Sasaki, Y; Koyama, T
      Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum

      JOURNAL OF MOLECULAR NEUROSCIENCE
    11. Christensen, HD; Rayburn, WF; Gonzalez, CL
      Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring

      NEUROTOXICOLOGY AND TERATOLOGY
    12. Fadda, F; Cocco, S; Rossetti, ZL; Melis, G; Stancampiano, R
      A tryptophan-free diet markedly reduces frontocortical 5-HT release, but fails to modify ethanol preference in alcohol-preferring (sP) and non-preferring (sNP) rats

      BEHAVIOURAL BRAIN RESEARCH
    13. Stein, MB; Norton, GR; Walker, JR; Chartier, MJ; Graham, R
      Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study

      PSYCHIATRY RESEARCH
    14. Bristow, LJ; O'Connor, D; Watts, R; Duxon, MS; Hutson, PH
      Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

      NEUROPHARMACOLOGY
    15. Deak, F; Lasztoczi, B; Pacher, P; Petheo, GL; Kecskemeti, V; Spat, A
      Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells

      NEUROPHARMACOLOGY
    16. Knobelman, DA; Kung, HF; Lucki, I
      Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT1A and 5-HT1B receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. Watanabe, K; Ashby, CR; Katsumori, H; Minabe, Y
      The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Johnson, BA; Ait-Daoud, N
      Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

      PSYCHOPHARMACOLOGY
    19. Cousins, MS; Seiden, LS
      The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-sschedule in rats

      PSYCHOPHARMACOLOGY
    20. Smith, DF
      Neuroimaging of serotonin uptake sites and antidepressant binding sites inthe thalamus of humans and 'higher' animals

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    21. Dardennes, R; Berdeaux, G; Lafuma, A; Fagnani, F
      Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs andSSRIs: a modeling approach

      EUROPEAN PSYCHIATRY
    22. Popik, P
      Preclinical pharmacology of citalopram

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    23. Baby, S; Nguyen, M; Tran, D; Raffa, RB
      Substance P antagonists: the next breakthrough in treating depression?

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    24. Winter, JC; Helsley, S; Fiorella, D; Rabin, RA
      The acute effects of monoamine reuptake inhibitors on the stimulus effectsof hallucinogens

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    25. Steinig, AG; Spero, DM
      Highly biastereoselective addition of Grignard reagents to aliphatic, enolizable N-alkylketimines and 2,2-disubstituted 1,3-oxazolidines. Asymmetric synthesis of the antidepressant cericlamine

      JOURNAL OF ORGANIC CHEMISTRY
    26. Hennings, ECP; Kiss, JP; De Oliveira, K; Toth, PT; Vizi, ES
      Nicotinic acetylcholine receptor antagonistic activity of monoamine uptakeblockers in rat hippocampal slices

      JOURNAL OF NEUROCHEMISTRY
    27. Ahlenius, S; Larsson, K
      Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. MUKHERJEE J; DAS MK; YANG ZY; LEW R
      EVALUATION OF THE BINDING OF THE RADIOLABELED ANTIDEPRESSANT DRUG, F-18 FLUOXETINE IN THE RODENT BRAIN - AN IN-VITRO AND IN-VIVO STUDY

      Nuclear medicine and biology
    29. HUANG HL; LIU LT; CHEN SF; KU H
      THE SYNTHESIS OF A CHIRAL FLUOXETINE INTERMEDIATE BY CATALYTIC ENANTIOSELECTIVE HYDROGENATION OF BENZOYLACETAMIDE

      Tetrahedron : asymmetry
    30. ZUCCARO P; PACIFICI R; ALTIERI I; AVENOSO A; PELLEGRINI M; SPINA E; PERUCCA E; PICHINI S
      ISSUES IN METHODOLOGY AND APPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS

      Therapeutic drug monitoring
    31. RAFFA RB
      POSSIBLE ROLE(S) OF NEUROKININS IN CNS DEVELOPMENT AND NEURODEGENERATIVE OR OTHER DISORDERS

      Neuroscience and biobehavioral reviews
    32. WATANABE K; MINABE Y; ASHBY CR; KATSUMORI H
      EFFECT OF ACUTE ADMINISTRATION OF VARIOUS 5-HT RECEPTOR AGONISTS ON FOCAL HIPPOCAMPAL SEIZURES IN FREELY MOVING RATS

      European journal of pharmacology
    33. GRIGNASCHI G; INVERNIZZI RW; FANELLI E; FRACASSO C; CACCIA S; SAMANIN R
      CITALOPRAM-INDUCED HYPOPHAGIA IS ENHANCED BY BLOCKADE OF 5-HT1A RECEPTORS - ROLE OF 5-HT2C RECEPTORS

      British Journal of Pharmacology
    34. PAGE ME; ABERCROMBIE ED
      AN ANALYSIS OF THE EFFECTS OF ACUTE AND CHRONIC FLUOXETINE ON EXTRACELLULAR NOREPINEPHRINE IN THE RAT HIPPOCAMPUS DURING STRESS

      Neuropsychopharmacology
    35. PERRY KW; FULLER RW
      FLUOXETINE INCREASES NOREPINEPHRINE RELEASE IN RAT HYPOTHALAMUS AS MEASURED BY TISSUE-LEVELS OF MHPG-SO4 AND MICRODIALYSIS IN CONSCIOUS RATS

      Journal of neural transmission
    36. CALLAHAN PM; CUNNINGHAM KA
      MODULATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE - COMPARISON OF THE EFFECTS OF FLUOXETINE WITH 5-HT1A AND 5-HT1B RECEPTOR AGONISTS

      Neuropharmacology
    37. KULKARNI SK; NINAN I; GUPTA YK; KAKKAR V
      ANTIDEPRESSANT DRUGS IN DISEASES OTHER THAN MENTAL DEPRESSION

      Medicamentos de actualidad
    38. JACKSON HC; NEEDHAM AM; HUTCHINS LJ; MAZURKIEWICZ SE; HEAL DJ
      COMPARISON OF THE EFFECTS OF SIBUTRAMINE AND OTHER MONOAMINE REUPTAKEINHIBITORS ON FOOD-INTAKE IN RAT THE

      British Journal of Pharmacology
    39. PICHINI S; PACIFICI R; ALTIERI I; PELLEGRINI M; ZUCCARO P
      STEREOSELECTIVE DETERMINATION OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PLASMA SAMPLES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of liquid chromatography & related technologies
    40. BOURIN M; BAKER GB
      DO G-PROTEINS HAVE A ROLE IN ANTIDEPRESSANT ACTIONS

      European neuropsychopharmacology
    41. RICCA V; MANNUCCI E; DIBERNARDO M; RIZZELLO SM; CABRAS PL; ROTELLA CM
      SERTRALINE ENHANCES THE EFFECTS OF COGNITIVE-BEHAVIORAL TREATMENT ON WEIGHT-REDUCTION OF OBESE PATIENTS

      Journal of endocrinological investigation
    42. KISELYOV AS; STREKOWSKI L
      THE TRIFLUOROMETHYL GROW IN ORGANIC-SYNTHESIS - A REVIEW

      Organic preparations and procedures international
    43. OKADA F; SAITO H; MATSUKI N
      PROPHYLACTIC EFFECT OF SEROTONIN UPTAKE INHIBITORS AGAINST MOTION SICKNESS IN SUNCUS-MURINUS

      European journal of pharmacology
    44. AGNEL M; ESNAUD H; LANGER SZ; GRAHAM D
      PHARMACOLOGICAL CHARACTERIZATION OF THE CLONED HUMAN 5-HYDROXYTRYPTAMINE TRANSPORTER

      Biochemical pharmacology
    45. HELMESTE DM; TANG SW; REIST C; VU R
      SEROTONIN UPTAKE INHIBITORS MODULATE INTRACELLULAR CA2+ MOBILIZATION IN PLATELETS (VOL 288, PG 373, 1995)

      European journal of pharmacology. Molecular pharmacology section
    46. HELMESTE DM; TANG SW; REIST C; VU R
      SEROTONIN UPTAKE INHIBITORS MODULATE INTRACELLULAR CA2+ MOBILIZATION IN PLATELETS

      European journal of pharmacology. Molecular pharmacology section
    47. WHEELER WJ; KUO FJ
      AN ASYMMETRIC-SYNTHESIS OF DULOXETINE HYDROCHLORIDE, A MIXED UPTAKE INHIBITOR OF SEROTONIN AND NOREPINEPHRINE, AND ITS C-14-LABELED ISOTOPOMERS

      Journal of labelled compounds & radiopharmaceuticals
    48. BARAK Y; LAMPL Y; ACHIRON A; SAROVAPINHAS I; ELIZUR A
      FLUOXETINE-INDUCED WEIGHT-LOSS - A PILOT-STUDY IN POSTPARTUM WOMEN

      Israel journal of psychiatry and related sciences
    49. GIARDINA WJ; BUCKNER SA; BRUNE ME; HANCOCK AA; WISMER CT; MILICIC I; RATTIN AJ; ROUX S; WETTSTEIN JG; MEYER MD; PORSOLT RD; KERWIN JF; WILLIAMS M
      A-80426, A POTENT AND SELECTIVE ALPHA(2)-ADRENOCEPTOR ANTAGONIST WITHSEROTONIN UPTAKE-BLOCKING ACTIVITY AND PUTATIVE ANTIDEPRESSANT-LIKE EFFECTS .2. PHARMACOLOGY PROFILE

      Drug development research
    50. FERNANDEZSOTO ML; BARREDOACEDO F; DELCASTILLO JDL; ESCOBARJIMENEZ F
      COMPARISON OF FLUOXETINE AND PLACEBO IN THE TREATMENT OF OBESITY

      Annals of nutrition & metabolism
    51. DEDEURWAERDERE P; BONHOMME N; LEMOAL M; SPAMPINATO U
      D-FENFLURAMINE INCREASES STRIATAL EXTRACELLULAR DOPAMINE IN-VIVO INDEPENDENTLY OF SEROTONERGIC TERMINALS OR DOPAMINE UPTAKE SITES

      Journal of neurochemistry
    52. ROEHR J; WOODS A; CORBETT R; KONGSAMUT S
      CHANGES IN PAROXETINE BINDING IN THE CEREBRAL-CORTEX OF POLYDIPSIC RATS

      European journal of pharmacology
    53. ADELL A; MYERS RD
      SELECTIVE DESTRUCTION OF MIDBRAIN RAPHE NUCLEI BY 5,7-DHT - IS BRAIN 5-HT INVOLVED IN ALCOHOL-DRINKING IN SPRAGUE-DAWLEY RATS

      Brain research
    54. MAVISSAKALIAN MR; PEREL JM
      IMIPRAMINE TREATMENT OF PANIC DISORDER WITH AGORAPHOBIA - DOSE-RANGING AND PLASMA LEVEL-RESPONSE RELATIONSHIPS

      The American journal of psychiatry
    55. CAGNOTTO A; BASTONE A; MENNINI T
      [H-3] (-PENTAZOCINE BINDING TO RAT-BRAIN SIGMA(1) RECEPTORS())

      European journal of pharmacology. Molecular pharmacology section
    56. MYERS RD
      NEW DRUGS FOR THE TREATMENT OF EXPERIMENTAL ALCOHOLISM

      Alcohol
    57. FAN P
      INHIBITION OF A 5-HT3 RECEPTOR-MEDIATED CURRENT BY THE SELECTIVE SEROTONIN UPTAKE INHIBITOR, FLUOXETINE

      Neuroscience letters
    58. LEBLHUBER F
      TREATMENT OF BEHAVIORAL ABNORMALITIES IN DEMENTED PATIENTS WITH CITALOPRAM

      Acta medica austriaca
    59. ARRANZ B; MARCUSSON J
      [3H]PAROXETINE AND [3H]CITALOPRAM AS MARKERS OF THE HUMAN BRAIN 5-HT UPTAKE SITE - A COMPARISON STUDY

      Journal of neural transmission
    60. FULLER RW; HEMRICKLUECKE SK; SNODDY HD
      FLUOXETINE AT ANORECTIC DOSES DOES NOT HAVE PROPERTIES OF A DOPAMINE UPTAKE INHIBITOR

      Journal of neural transmission
    61. OKADA F; TOKUMITSU Y
      IS THE BETA-DOWN-REGULATION A PREREQUISITE OF THE ANTIDEPRESSANT ACTIVITY

      JOURNAL OF PSYCHOPHARMACOLOGY
    62. GRAM LF
      DRUG-THERAPY - FLUOXETINE

      The New England journal of medicine
    63. SANNERUD CA; PRADA J; GOLDBERG DM; GOLDBERG SR
      THE EFFECTS OF SERTRALINE ON NICOTINE SELF-ADMINISTRATION AND FOOD-MAINTAINED RESPONDING IN SQUIRREL-MONKEYS

      European journal of pharmacology
    64. PALVIMAKI EP; LAAKSO A; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS

      Psychopharmacology
    65. SIGAL SL; GELLMAN J; ANDERSON GM; TRUE LD; CHEN QS; TSELENTAKIS MJ; LING FS; EZEKOWITZ MD
      POTENTIATION OF THE VASOSPASTIC RESPONSE TO ANGIOPLASTY BY PRETREATMENT WITH FLUOXETINE - A STUDY IN THE ATHEROSCLEROTIC RABBIT

      Arteriosclerosis and thrombosis
    66. COREY EJ; REICHARD GA; SARSHAR S
      SYNTHESIS AND X-RAY STRUCTURE OF A POTENT SUPERPOSITIONAL ANALOG OF THE ENANTIOMERIC FORMS OF FLUOXETINE

      Bioorganic & medicinal chemistry letters
    67. GARCIA MJ; REBOLLEDO F; GOTOR V
      PRACTICAL ENZYMATIC ROUTE TO OPTICALLY-ACTIVE 3-HYDROXYAMIDES - SYNTHESIS OF 1,3-AMINOALCOHOLS

      Tetrahedron : asymmetry
    68. HANDLEY SL; MCBLANE JW; CRITCHLEY MAE; NJUNGE K
      MULTIPLE SEROTONIN MECHANISMS IN ANIMAL-MODELS OF ANXIETY - ENVIRONMENTAL, EMOTIONAL AND COGNITIVE-FACTORS

      Behavioural brain research
    69. PAYKEL ES
      RECENT DEVELOPMENTS IN ANTIDEPRESSANTS

      Current therapeutic research
    70. PRATT GD; BOWERY NG
      REPEATED ADMINISTRATION OF DESIPRAMINE AND A GABA(B) RECEPTOR ANTAGONIST, CGP-36742, DISCRETELY UP-REGULATES GABA(B) RECEPTOR-BINDING SITESIN RAT FRONTAL-CORTEX

      British Journal of Pharmacology
    71. LITTLE KY; CLARK TB; RANC J; DUNCAN GE
      BETA-ADRENERGIC-RECEPTOR BINDING IN FRONTAL-CORTEX FROM SUICIDE VICTIMS

      Biological psychiatry
    72. SCHREIBER R; OPITZ K; GLASER T; DEVRY J
      IPSAPIRONE AND 8-OH-DPAT REDUCE ETHANOL PREFERENCE IN RATS - INVOLVEMENT OF PRESYNAPTIC 5-HT(1A) RECEPTORS

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 03:21:25